Corvex AI Stock Analysis
Want to see MOVE full AI Analyst Report?
Corvex (MOVE) AI Stock Analysis
Corvex
(NASDAQ:MOVE)
MOVE scores low primarily because the operating business remains unproven: it sells at a negative gross margin, posted roughly $41M of TTM losses, and is burning cash at an accelerating pace, leaving the investment case dependent on future execution. Technicals reinforce the caution, with the price far below all major moving averages and negative MACD, though oversold RSI and Stochastic readings hint at potential short-term stabilization. Partially offsetting these risks is a very strong, essentially debt-free balance sheet with roughly $598M of equity that funds a multi-year runway, plus encouraging earnings-call execution — fully contracted near-term capacity, about $22M of contracted ARR and expansions on schedule. Negative earnings and no dividend leave valuation unsupportive, and the unremediated internal-control weakness, customer concentration and ongoing equity issuance (ATM program) add dilution and governance risk.
Corvex (MOVE) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $148.61M
- Dividend Yield
- ―
- Average Volume (3M)
- 268.68K
- Price to Earnings (P/E)
- -0.4
- Beta (1Y)
- 1.99
- Revenue Growth
- 1767.40%
- EPS Growth
- 19.21%
- Country
- US
- Employees
- 38
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Infrastructure
Corvex Business Overview & Revenue Model
Company Description
Corvex, Inc., an AI cloud computing company, provides GPU-accelerated infrastructure for AI workloads to customers worldwide. The company provides graphics processing unit accelerated compute, confidential computing, token factory, and inference serv...
How the Company Makes Money
Movano’s monetization is expected to come primarily from commercializing its device-and-software ecosystem. Potential revenue streams include: (1) sales of wearable hardware devices (one-time revenue per unit sold); (2) recurring software and service...
Corvex Earnings Call Summary
The call was broadly positive, with strong execution against the stated plan, all 7.7 megawatts of planned capacity under contract, data center expansions on schedule, a successful Token Factory launch, improving liquidity and encouraging customer and financing discussions. The positive developments were tempered by a $17.5 million net loss, ongoing large noncash stock-based compensation, operating cash use, customer and revenue concentration, the absence of near-term Token Factory revenue, increased competitive and credit requirements, and an unremediated material weakness in internal controls.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Corvex expects to grow critical IT capacity from approximately 1.5 megawatts to approximately 8 megawatts by the end of 2026, with the right of first refusal on an additional 12.5 megawatts that could take total Corvex capacity past 20 megawatts in 2027; the remaining 6.2 megawatts across Midwest-1 and the Mid-Atlantic-1 expansion are on track to be ready for service in the fourth quarter of 2026, with Midwest-1 expected to be delivered from the start of construction to anticipated ready for service in under 2 quarters. Corvex is in final discussions with a rapidly growing AI native to take over 1,000 NVIDIA Blackwells for 3 years, expects Token Factory to make a meaningful contribution beginning in 2027, will focus on demand and onboarding partners and channels over the next 2 quarters, and expects to begin testing operating effectiveness of controls in the first half of 2027.
Corvex Financial Statement Overview
Summary
Mixed picture dominated by weak operations. Revenue is inflecting sharply (about $9.3M TTM versus $0.4M in fiscal 2025), but the company still sells at a gross loss (-$0.3M), posted a TTM net loss of roughly $41M, and burned about $35M in free cash flow with capex accelerating. The offset is an exceptionally strong, newly recapitalized balance sheet: roughly $598M of equity against only about $20M of debt (debt-to-equity near 0.03), providing a long funding runway. Income statement (22) and cash flow (25) scores are very weak, partially balanced by a solid balance sheet score of 74.
Income Statement
22NegativeBalance Sheet
74PositiveCash Flow
25Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.34M | 433.00K | 1.01M | 0 | 0 | 0 |
| Gross Profit | -300.00K | -1.84M | -1.99M | -158.00K | -134.00K | 0 |
| EBITDA | -35.75M | -15.17M | -23.56M | -29.13M | -30.18M | -20.82M |
| Net Income | -41.14M | -18.29M | -23.73M | -29.28M | -30.20M | -22.58M |
Balance Sheet | ||||||
| Total Assets | 627.69M | 5.60M | 11.32M | 9.42M | 13.24M | 36.27M |
| Cash, Cash Equivalents and Short-Term Investments | 41.99M | 2.83M | 7.90M | 6.12M | 10.76M | 33.60M |
| Total Debt | 20.30M | 4.90M | 186.00K | 217.00K | 426.00K | 0 |
| Total Liabilities | 29.34M | 9.07M | 3.96M | 5.97M | 5.33M | 3.54M |
| Stockholders Equity | 598.35M | -3.47M | 7.36M | 3.45M | 7.92M | 32.73M |
Cash Flow | ||||||
| Free Cash Flow | -34.85M | -11.27M | -22.54M | -26.24M | -25.01M | -16.75M |
| Operating Cash Flow | -18.83M | -11.27M | -22.53M | -26.18M | -24.90M | -16.18M |
| Investing Cash Flow | 20.02M | 0 | -8,000 | -64.00K | 15.72M | -16.70M |
| Financing Cash Flow | 39.53M | 6.19M | 24.32M | 21.60M | 2.26M | 44.85M |
Corvex Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MOVE, the sentiment is Negative. The current price of 4.71 is below the 20-day moving average (MA) of 6.78, below the 50-day MA of 9.45, and below the 200-day MA of 12.85, indicating a bearish trend. The MACD of -1.28 indicates Positive momentum. The RSI at 28.33 is Positive, neither overbought nor oversold. The STOCH value of 25.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MOVE.
Corvex Risk Analysis
Corvex disclosed 89 risk factors in its most recent earnings report. Corvex reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksCorvex Peers Comparison
Overall Rating
- MOVE44Neutral
BJDX44Neutral
AMIX40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| MOVE | 44Neutral | $179.85M | -0.40 | -9.44% | ― | 1767.40% | 19.21% |
| BJDX | 44Neutral | $3.13M | -0.07 | -125.01% | ― | ― | 93.91% |
| AMIX | 40Underperform | $3.03M | -0.07 | -191.88% | ― | ― | 81.59% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MOVE | Corvex, Inc. | 4.71 | -3.17 | -40.22% | |
| BBLG | Bone Biologics Corp | 0.40 | -1.20 | -75.00% | |
| BJDX | Bluejay Diagnostics, Inc. | 2.60 | -21.07 | -89.00% | |
| AMIX | Autonomix Medical, Inc. | 1.35 | -13.91 | -91.12% |
Corvex Corporate Events
Corvex Launches ATM Equity Program With Chardan Capital
PositiveOn October 14, 2026, Corvex, Inc. entered into an at-the-market sales agreement with Chardan Capital Markets LLC, appointing the firm as sales agent, and in certain periods as exclusive agent, to place shares of Corvex’s common stock under a shelf re...
Corvex finalizes Movano merger and equity restructuring
NeutralOn March 19, 2026, Corvex, Inc., formerly Movano Inc., completed its merger with Corvex Legacy Holdings, Inc., making Corvex OpCo a wholly owned subsidiary and later adopting the Corvex name on March 23, 2026. The consideration, structured through Se...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 13, 2026